SCHEMBL1823491

SCHEMBL1823491

CCOC(=O)C(c1cccc(OS(=O)(=O)c2ccc(C)cc2)c1)C(N)C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.37
GAA P10253 3/20 0.36
MAPT P10636 1/20 0.36
G6PD P11413 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
GPR17 Q13304 1/20 0.35
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAOB P27338 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824362 0.95 CASP3 (0.37) GAAALDH1A1MAPK1TDP1L3MBTL1
SCHEMBL1824941 0.93 MAPT (0.38) DHODHGAAMAPTG6PDNPSR1
SCHEMBL1823539 0.92 P2RX7 (0.39) DHODHGAAMAPTG6PDNPSR1
SCHEMBL1824563 0.91 GPR17 (0.36) DHODHGAAMAPTG6PDNPSR1
SCHEMBL1826387 0.91 ALDH1A1 (0.36) DHODHGAAMAPTALDH1A1HPGD
SCHEMBL1826700 0.91 P2RX7 (0.36) DHODHGAAMAPTG6PDNPSR1
SCHEMBL1825016 0.88 DHODH (0.35) DHODHGAAMAPTG6PDNPSR1
SCHEMBL1827109 0.88 CASP3 (0.38) KMT2AEPHX2CA1CA2CASP3
SCHEMBL1825579 0.86 CASP3 (0.40) KMT2AEPHX2CA1CA2CASP3
SCHEMBL1828565 0.85 CASP3 (0.38) MAPTALDH1A1HPGDTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 DHODH 2965/4885GAA 2170/4885MAPT 4712/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 DHODH 1171/4885GAA 98/4885MAPT 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.